Despite a recent 45% rally, I maintain a 'Sell' view on CVS due to its underwhelming execution record and rising leverage ...

CVS Health reported $4.6 billion in 2024 profit including $1.6 billion in the fourth quarter as its health insurance business ...

CVS Health’s total revenue for the full year 2024 increased 4.2% to $372.8 billion, but within the healthcare benefits ...

CVS Health (NYSE:CVS – Free Report) had its price target lifted by JPMorgan Chase & Co. from $80.00 to $81.00 in a report ...

HARTFORD-- This week, the CEO of CVS Health expressed confidence that the company would turn around its embattled health-insurance business, the Hartford- based Aetna. "People used to refer to Aetna ...

In the latest executive shakeup at CVS, the pharmacy giant has named a new president of its pharmacy benefit management ...

CVS Health Corp (NYSE:CVS) reported fourth-quarter sales of $97.71 billion, beating the consensus of $97.19 billion. Total ...

We recently compiled a list of the 10 Best Performing S&P 500 Stocks So Far in 2025. In this article, we are going to take a ...

Argus raised the firm’s price target on CVS Health (CVS) to $77 from $68 and keeps a Buy rating on the shares. Despite an uneven performance ...

CVS Health investors were breathing a big sigh of relief Wednesday after the healthcare services behemoth reported ...

CVS Health’s adjusted fourth-quarter profit handily beat Wall Street’s estimates, even as the drugstore chain and pharmacy ...

CVS Health posted stronger-than-expected fourth quarter earnings Wednesday, including a narrowing of its key benefit-expense ...